Topfond Pharmaceutical Co., Ltd.

Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.

This source was last successfully updated at 2026/11/12 18:32; current coverage may be incomplete.

Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.

Accepted: 16 applicationsNo longer listed under review: 6 applicationsSupplement delivery: 6 applications

1. 2026/11/06No longer listed under review

   感冒灵片 · No verified English name

   CYZB2604856

   Fact date: 2026/11/06 · Site observation date: 2026/11/06

   Accepted: 2026/09/20

   not on the CDE under-review list in this snapshot; NMPA published approval-document delivery for this acceptance number on 2026/11/06 (approval no.: —; approval date: 2026/11/04); this is a supplemental application, not counted as a new marketing approval · NMPA source · row 172

   NMPA · Table row 172 ↗ View source ↗
2. 2026/11/06No longer listed under review

   橘红颗粒 · No verified English name

   CYZB2603936

   Fact date: 2026/11/06 · Site observation date: 2026/11/06

   Accepted: 2026/08/06

   not on the CDE under-review list in this snapshot; NMPA published approval-document delivery for this acceptance number on 2026/11/06 (approval no.: —; approval date: 2026/11/04); this is a supplemental application, not counted as a new marketing approval · NMPA source · row 99

   NMPA · Table row 99 ↗ View source ↗
3. 2026/11/05No longer listed under review

   参芪消渴颗粒 · No verified English name

   CYZB2603945

   Fact date: 2026/11/05 · Site observation date: 2026/11/05

   Accepted: 2026/08/06

   not on the CDE under-review list in this snapshot; NMPA published approval-document delivery for this acceptance number on 2026/11/04 (approval no.: —; approval date: 2026/11/03); this is a supplemental application, not counted as a new marketing approval · NMPA source · row 38

   NMPA · Table row 38 ↗ View source ↗
4. 2026/11/04Supplement delivery

   感冒灵片 · No verified English name

   CYZB2604856

   Fact date: 2026/11/04 · Publication date: 2026/11/06 · Site observation date: 2026/11/06

   Supplemental application; excluded from new marketing approvals.

   View source · Table row 172 ↗
5. 2026/11/04Supplement delivery

   橘红颗粒 · No verified English name

   CYZB2603936

   Fact date: 2026/11/04 · Publication date: 2026/11/06 · Site observation date: 2026/11/06

   Supplemental application; excluded from new marketing approvals.

   View source · Table row 99 ↗
6. 2026/11/04No longer listed under review

   麦味地黄口服液 · No verified English name

   CYZB2603954

   Fact date: 2026/11/04 · Site observation date: 2026/11/04

   Accepted: 2026/08/07

   not on the CDE under-review list in this snapshot; NMPA published approval-document delivery for this acceptance number on 2026/11/03 (approval no.: —; approval date: 2026/11/02); this is a supplemental application, not counted as a new marketing approval · NMPA source · row 91

   NMPA · Table row 91 ↗ View source ↗
7. 2026/11/04No longer listed under review

   当归片 · No verified English name

   CYZB2603953

   Fact date: 2026/11/04 · Site observation date: 2026/11/04

   Accepted: 2026/08/07

   not on the CDE under-review list in this snapshot; NMPA published approval-document delivery for this acceptance number on 2026/11/03 (approval no.: —; approval date: 2026/11/02); this is a supplemental application, not counted as a new marketing approval · NMPA source · row 90

   NMPA · Table row 90 ↗ View source ↗
8. 2026/11/04No longer listed under review

   华山参片 · No verified English name

   CYZB2603935

   Fact date: 2026/11/04 · Site observation date: 2026/11/04

   Accepted: 2026/08/06

   not on the CDE under-review list in this snapshot; NMPA published approval-document delivery for this acceptance number on 2026/11/03 (approval no.: —; approval date: 2026/11/02); this is a supplemental application, not counted as a new marketing approval · NMPA source · row 88

   NMPA · Table row 88 ↗ View source ↗
9. 2026/11/03Supplement delivery

   参芪消渴颗粒 · No verified English name

   CYZB2603945

   Fact date: 2026/11/03 · Publication date: 2026/11/04 · Site observation date: 2026/11/04

   Supplemental application; excluded from new marketing approvals.

   View source · Table row 38 ↗
10. 2026/11/02Supplement delivery

    麦味地黄口服液 · No verified English name

    CYZB2603954

    Fact date: 2026/11/02 · Publication date: 2026/11/03 · Site observation date: 2026/11/03

    Supplemental application; excluded from new marketing approvals.

    View source · Table row 91 ↗
11. 2026/11/02Supplement delivery

    当归片 · No verified English name

    CYZB2603953

    Fact date: 2026/11/02 · Publication date: 2026/11/03 · Site observation date: 2026/11/03

    Supplemental application; excluded from new marketing approvals.

    View source · Table row 90 ↗
12. 2026/11/02Supplement delivery

    华山参片 · No verified English name

    CYZB2603935

    Fact date: 2026/11/02 · Publication date: 2026/11/03 · Site observation date: 2026/11/03

    Supplemental application; excluded from new marketing approvals.

    View source · Table row 88 ↗
13. 2026/10/26Accepted

    苯磺酸美洛加巴林口崩片 · No verified English name

    CYHS2602617

    Fact date: 2026/10/26 · Site observation date: 2026/10/27

    View source ↗
14. 2026/10/26Accepted

    苯磺酸美洛加巴林口崩片 · No verified English name

    CYHS2602616

    Fact date: 2026/10/26 · Site observation date: 2026/10/27

    View source ↗
15. 2026/10/23Accepted

    穿心莲片 · No verified English name

    CYZB2605311

    Fact date: 2026/10/23 · Site observation date: 2026/10/24

    View source ↗
16. 2026/10/23Accepted

    板蓝根颗粒 · No verified English name

    CYZB2605310

    Fact date: 2026/10/23 · Site observation date: 2026/10/24

    View source ↗
17. 2026/10/19Accepted

    羚羊感冒胶囊 · No verified English name

    CYZB2605203

    Fact date: 2026/10/19 · Site observation date: 2026/10/22

    View source ↗
18. 2026/10/19Accepted

    心可宁胶囊 · No verified English name

    CYZB2605202

    Fact date: 2026/10/19 · Site observation date: 2026/10/22

    View source ↗
19. 2026/10/12Accepted

    风湿定胶囊 · No verified English name

    CYZB2605107

    Fact date: 2026/10/12 · Site observation date: 2026/10/22

    View source ↗
20. 2026/10/12Accepted

    产妇安颗粒 · No verified English name

    CYZB2605097

    Fact date: 2026/10/12 · Site observation date: 2026/10/22

    View source ↗
21. 2026/09/21Accepted

    Tadalafil Tablets

    CYHB2601781

    Fact date: 2026/09/21 · Site observation date: 2026/10/22

    View source ↗
22. 2026/09/21Accepted

    Tadalafil Tablets

    CYHB2601780

    Fact date: 2026/09/21 · Site observation date: 2026/10/22

    View source ↗
23. 2026/09/20Accepted

    感冒灵片 · No verified English name

    CYZB2604856

    Fact date: 2026/09/20 · Site observation date: 2026/10/22

    View source ↗
24. 2026/09/08Accepted

    乳泉颗粒 · No verified English name

    CYZB2604599

    Fact date: 2026/09/08 · Site observation date: 2026/10/22

    View source ↗
25. 2026/08/27Accepted

    茸参益肾胶囊 · No verified English name

    CYZB2604379

    Fact date: 2026/08/27 · Site observation date: 2026/10/22

    View source ↗
26. 2026/08/27Accepted

    清热解毒口服液 · No verified English name

    CYZB2604378

    Fact date: 2026/08/27 · Site observation date: 2026/10/22

    View source ↗
27. 2026/08/27Accepted

    逍遥颗粒 · No verified English name

    CYZB2604374

    Fact date: 2026/08/27 · Site observation date: 2026/10/22

    View source ↗
28. 2026/08/27Accepted

    骨刺消痛胶囊 · No verified English name

    CYZB2604372

    Fact date: 2026/08/27 · Site observation date: 2026/10/22

    View source ↗

Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.

Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.

CDE acceptances and review

Last successful update: 2026/11/13 06:42

Chemical-drug catalogue

Last successful update: 2026/11/13 06:39

Full API register

Last successful update: 2026/11/13 06:41

NMPA drug delivery notices

Last successful update: 2026/11/12 18:32 · Current coverage may be incomplete

First index-page publication dates: 2026-10-29 to 2026-11-13; 2 pages pending. Covers loaded notices only, not a complete historical approval database.

Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.

Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.

Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.

Public drug landscapes ↗